Strong Week for Alcidion Group (ASX:ALC) Shareholders Doesn't Alleviate Pain of Three-year Loss
Alcidion Logs AU$10 Million Cash Receipts in Fiscal Q3
Alcidion (ASX:ALC) logged AU$10.2 million in cash receipts in the fiscal third quarter ended March, according to a Thursday filing with the Australian Securities Exchange. Further, the healthcare tech
Alcidion Group Extends Contract With Dartford and Gravesham NHS Trust; Shares Down 4%
Healthcare technology company Alcidion Group (ASX:ALC) signed a three-year contract extension with Dartford and Gravesham NHS Trust for use of its Miya Precision platform and associated modules, accor
Alcidion's Cost Cuts Make Sense to Bell Potter -- Market Talk
2315 GMT - Healthcare-software provider Alcidion's decision to cut staff looks prudent to Bell Potter analyst Thomas Wakim. The Australia-listed company announced further cost cuts in response to pers
Alcidion Price Target Cut 38% to A$0.05/Share by Bell Potter
Alcidion Price Target Cut 38% to A$0.05/Share by Bell Potter
Alcidion Group Limited (ASX:ALC) Analysts Are More Bearish Than They Used To Be
Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Its Share Price
Alcidion Group Nabs Eight-Year Contract Extension With South Tees Hospital NHS Foundation Trust
Alcidion Group (ASX:ALC) secured an eight-year extension for its contract with South Tees Hospital NHS Foundation Trust. The contract was for the use of the company's Miya Precision EPR platform and B
Here's Why Shareholders May Want To Be Cautious With Increasing Alcidion Group Limited's (ASX:ALC) CEO Pay Packet
Alcidion Group Opens AU$1 Million Share Purchase Plan; Shares Slide 4%
Alcidion Group (ASX:ALC) opened a AU$1.0 million share purchase plan of 13.3 million ordinary shares at AU$0.075 apiece. Proceeds will be used to maintain a strong balance sheet to drive future revenu
Alcidion Loses Bull After 1Q Cash Receipts Disappoint -- Market Talk
0310 GMT - Alcidion's disappointing 1Q performance and capital raising lose it a bull at Bell Potter, where analyst Thomas Wakim is waiting for the medical software provider to execute on new contract
Alcidion Price Target Cut 50% to A$0.08/Share by Bell Potter
Alcidion Price Target Cut 50% to A$0.08/Share by Bell Potter
Alcidion Downgraded to Hold From Buy by Bell Potter
Alcidion Downgraded to Hold From Buy by Bell Potter
Alcidion Group Limited's (ASX:ALC) Intrinsic Value Is Potentially 35% Above Its Share Price
Is Now The Time To Look At Buying Alcidion Group Limited (ASX:ALC)?
Alcidion Price Target Raised 6.7% to A$0.16/Share by Bell Potter
Alcidion Price Target Raised 6.7% to A$0.16/Share by Bell Potter
Alcidion Price Target Cut 20% to A$0.16/Share by RBC Capital Markets
Alcidion Price Target Cut 20% to A$0.16/Share by RBC Capital Markets
Alcidion's Revenue Growth Highlights Its Stability -- Market Talk
0049 GMT - Alcidion's 4Q update prompts Bell Potter analyst Thomas Wakim to raise his revenue forecasts for the Australian health-tech provider. Wakim points to the ASX-listed company's record quarter
Alcidion Price Target Raised 25% to A$0.15/Share by Bell Potter
Alcidion Price Target Raised 25% to A$0.15/Share by Bell Potter
Alcidion Group (ASX:ALC) Shareholders Have Earned a 17% CAGR Over the Last Five Years
No Data